Adagene Company
Adagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies.
Industry:
End-to-end Drug Development
Headquarters:
Suzhou, Jiangsu, China
Founded Date:
2011-01-01
Employees Number:
51-100
Funding Status:
IPO
Investors Number:
11
Total Funding:
155000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-02-11
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership